Alpha Tau Medical (DRTS) Total Liabilities (2020 - 2026)
Alpha Tau Medical's (DRTS) quarterly Total Liabilities came in at $39.4 million in Q1 2026, up 60.23% year-on-year from $24.6 million in Q1 2025, and up 38.06% quarter-over-quarter from $28.6 million in Q4 2025.
Alpha Tau Medical (DRTS) Total Liabilities (2020 - 2026) Analysis & Trends
Alpha Tau Medical has disclosed Total Liabilities across 7 years of filings, most recently posting $39.4 million for Q1 2026.
- Total Liabilities for Q1 2026 came in at $39.4 million, up 60.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.4 million (up 60.23% YoY), and the FY2025 annual result was $28.6 million, up 21.31% from the prior year.
- Total Liabilities came in at $39.4 million for Q1 2026 at Alpha Tau Medical, up from $28.6 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $39.4 million in Q1 2026 to a low of $12.1 million in Q3 2022.
- The 5-year median for Total Liabilities is $22.9 million (2023), against an average of $22.2 million.
- Across the five-year window, Total Liabilities plunged 37.07% in 2022 and jumped 60.23% in 2026, its largest moves.
- Alpha Tau Medical's Total Liabilities stood at $14.5 million in 2022, then soared by 58.11% to $22.9 million in 2023, then grew by 2.73% to $23.5 million in 2024, then advanced by 21.31% to $28.6 million in 2025, then jumped by 38.06% to $39.4 million in 2026.
- The last three Total Liabilities figures came in at $39.4 million (Q1 2026), $28.6 million (Q4 2025), and $27.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 19.51 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 10.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 137.56 Mn |
| 10 | Alpha Tau Medical | 2,416.70 | -76.42 Mn | - | 39.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.42 Mn |
| Dec 31, 2025 | 28.55 Mn |
| Sep 30, 2025 | 27.11 Mn |
| Jun 30, 2025 | 24.33 Mn |
| Mar 31, 2025 | 24.60 Mn |
| Dec 31, 2024 | 23.54 Mn |
| Sep 30, 2024 | 21.33 Mn |
| Jun 30, 2024 | 22.03 Mn |
| Mar 31, 2024 | 23.38 Mn |
| Dec 31, 2023 | 22.91 Mn |
| Sep 30, 2023 | 16.89 Mn |
| Jun 30, 2023 | 18.64 Mn |
| Mar 31, 2023 | 16.88 Mn |
| Dec 31, 2022 | 14.49 Mn |
| Sep 30, 2022 | 12.11 Mn |
| Jun 30, 2022 | 15.71 Mn |
| Mar 31, 2022 | 25.05 Mn |
| Dec 31, 2021 | 23.03 Mn |
| Dec 31, 2020 | 7.45 Mn |